Novo Nordisk

Novo Nordisk to cut US list prices of two insulin products by more than 70%
MSN/Reuters
Thu, 12/5/24 - 04:14 pm
Novo Nordisk
drug pricing
insulin
Fiasp
Tresiba
diabetes
Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
Fierce Pharma
Thu, 12/5/24 - 11:17 am
Novo Nordisk
Denmark
drug manufacturing
Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives
BioPharma Dive
Wed, 12/4/24 - 11:15 pm
Antag Therapeutics
Versant
Novo Nordisk
obesity
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
Yahoo/Reuters
Wed, 12/4/24 - 11:08 am
Novavax
Novo Nordisk
czech republic
drug manufacturing
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Novo Nordisk
India
Wegovy
Eli Lilly
Zepbound
Four oral GLP-1R products in Phase III trials as race intensifies
Clinical Trials Arena
Tue, 12/3/24 - 11:17 am
Novo Nordisk
Eli Lilly
Jiangsu Hengrui
GLP-1R
GLP-1 agonists
clinical trials
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
MSN
Wed, 11/27/24 - 09:57 pm
Novo Nordisk
Wegovy
Canada
Health Canada
obesity
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk
Fierce Pharma
Mon, 11/25/24 - 11:43 am
Pfizer
earnings
Eli Lilly
Novo Nordisk
Novo, Viking heat up MASH space with promising data at AASLD24
BioSpace
Wed, 11/20/24 - 11:40 am
Novo Nordisk
Viking Therapeutics
MASH
AASLD
GLP-1 agonists
semaglutide
VK2809
Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wed, 11/20/24 - 11:21 am
Novo Nordisk
Eli Lilly
obesity
weight loss
GLP-1 agonists
compounded drugs
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Mon, 11/18/24 - 11:28 am
Novo Nordisk
Wegovy
Cina
weight loss
GLP-1 agonists
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO
Beckers Hospital Review
Thu, 11/7/24 - 11:14 am
Novo Nordisk
Ozempic
semaglutide
compounded drugs
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail
Fierce Biotech
Wed, 11/6/24 - 08:00 pm
Novo Nordisk
kidney disease
clinical trials
ocedurenon
Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year
Yahoo Finance
Wed, 11/6/24 - 11:44 am
Novo Nordisk
Wegovy
earnings
States slow to cover GLP-1s for weight loss
Axios
Wed, 11/6/24 - 11:37 am
Medicaid
GLP-1 agonists
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
Wegovy reduces all-cause admissions: 3 study findings
Beckers Hospital Review
Mon, 11/4/24 - 11:19 am
Novo Nordisk
Wegovy
hospital admissions
clinical trials

Pages